Carol Aghajanian, MD [clinicaltrials_resource:91720bfecf03d1b7e21b96d7a5af81c1]
Paclitaxel in Treating Patients With Recurrent or Progressive Advanced Ovarian Cancer [clinicaltrials:NCT00002928]Irofulven in Treating Patients With Stage IVB or Recurrent Cervical Cancer [clinicaltrials:NCT00005070]Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer [clinicaltrials:NCT00005999]Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [clinicaltrials:NCT00028912]
overall official [clinicaltrials_vocabulary:overall-official]
Carol Aghajanian, MD [clinicaltrials_resource:91720bfecf03d1b7e21b96d7a5af81c1]
Bio2RDF identifier
91720bfecf03d1b7e21b96d7a5af81c1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:91720bfecf03d1b7e21b96d7a5af81c1
affiliation [clinicaltrials_vocabulary:affiliation]
last name [clinicaltrials_vocabulary:last-name]
Carol Aghajanian, MD
role [clinicaltrials_vocabulary:role]
Study Chair
identifier
clinicaltrials_resource:91720bfecf03d1b7e21b96d7a5af81c1
title
Carol Aghajanian, MD
@en
type
label
Carol Aghajanian, MD [clinicaltrials_resource:91720bfecf03d1b7e21b96d7a5af81c1]
@en